Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastien Gallien

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Data in Brief|February 11, 2016
Dataset on protein composition of a human plasma sub-proteome able to modulate the Dengue 2 virus infection in Huh 7.5 cellsVivian Huerta, Yassel Ramos, Alexis Yero, et al.
Emerging Infectious Diseases|June 25, 2025
Disseminated Histoplasmosis in Persons Living with HIV, France and Overseas Territories,1992-2021Mathieu Nacher, Esaïe Marshall, Firouze Bani-Sadr, et al.
AIDS (London, England)|August 23, 2011
Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262)Babafemi Taiwo, Lu Zheng, Sebastien Gallien, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2018
Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight)Jean-Michel Molina, Sebastien Gallien, Marie-Laure Chaix, et al.
Journal of Proteomics|July 18, 2017
An "on-matrix" digestion procedure for AP-MS experiments dissects the interplay between complex-conserved and serotype-specific reactivities in Dengue virus-human plasma interactomeYassel Ramos, Vivian Huerta, Dayron Martín, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2018
First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2)Sophie Matheron, Diane Descamps, Sebastien Gallien, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 25, 2024
Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccineSimon B Gressens, Vincent Enouf, Antoine Créon, et al.
Journal of Proteomics|November 8, 2015
Novel interactions of domain III from the envelope glycoprotein of dengue 2 virus with human plasma proteinsVivian Huerta, Yassel Ramos, Alexis Yero, et al.
JACC. Cardiovascular Imaging|December 17, 2018
Characterization of 18-Fluorodeoxyglucose Uptake Pattern in Infective Endocarditis After Transcatheter Aortic Valve ImplantationSovannarith San, Mukedaisi Abulizi, Amina Moussafeur, et al.
The Journal of Infectious Diseases|March 6, 2013
Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantationTimothy J Henrich, Zixin Hu, Jonathan Z Li, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Data in Brief|February 11, 2016
Dataset on protein composition of a human plasma sub-proteome able to modulate the Dengue 2 virus infection in Huh 7.5 cellsVivian Huerta, Yassel Ramos, Alexis Yero, et al.
Emerging Infectious Diseases|June 25, 2025
Disseminated Histoplasmosis in Persons Living with HIV, France and Overseas Territories,1992-2021Mathieu Nacher, Esaïe Marshall, Firouze Bani-Sadr, et al.
AIDS (London, England)|August 23, 2011
Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262)Babafemi Taiwo, Lu Zheng, Sebastien Gallien, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2018
Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight)Jean-Michel Molina, Sebastien Gallien, Marie-Laure Chaix, et al.
Journal of Proteomics|July 18, 2017
An "on-matrix" digestion procedure for AP-MS experiments dissects the interplay between complex-conserved and serotype-specific reactivities in Dengue virus-human plasma interactomeYassel Ramos, Vivian Huerta, Dayron Martín, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2018
First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2)Sophie Matheron, Diane Descamps, Sebastien Gallien, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 25, 2024
Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccineSimon B Gressens, Vincent Enouf, Antoine Créon, et al.
Journal of Proteomics|November 8, 2015
Novel interactions of domain III from the envelope glycoprotein of dengue 2 virus with human plasma proteinsVivian Huerta, Yassel Ramos, Alexis Yero, et al.
JACC. Cardiovascular Imaging|December 17, 2018
Characterization of 18-Fluorodeoxyglucose Uptake Pattern in Infective Endocarditis After Transcatheter Aortic Valve ImplantationSovannarith San, Mukedaisi Abulizi, Amina Moussafeur, et al.
The Journal of Infectious Diseases|March 6, 2013
Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantationTimothy J Henrich, Zixin Hu, Jonathan Z Li, et al.
Pageof 5